Evidence map›Paper›PMID 33005721›Full record

ArticleGynecologic oncology reports2020

Potential effect of intravenous immunoglobulin against paraneoplastic cerebellar degeneration in progressive ovarian cancer.

Takashi Shibata, Tetsuya Oishi, Yasunori Fukuoka, Shigeki Nishikawa, Noriaki Iizuka, Hiroki Kato

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takashi ShibataDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Tetsuya OishiDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Yasunori FukuokaDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Shigeki NishikawaDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Noriaki IizukaDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Hiroki KatoDepartment of Obstetrics and Gynecology, Takatsuki General Hospital, 1-3-13 Kosobe-Cho Takatsuki, Osaka 569-1192, Japan.
Takatsuki General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the effect of intravenous immunoglobulin (IVIG) against paraneoplastic cerebellar degeneration (PCD) in a case of progressive ovarian cancer. Our patient developed PCD soon after postoperative chemotherapy and became bedridden. After undergoing IVIG, however, symptoms dramatically improved, and unexpectedly the remaining tumors were confirmed to have completely disappeared. When PCD is diagnosed, IVIG treatment should be attempted to reduce neuropathy regardless of its degree and the state of the cancer. It may also have further potential benefits that should be considered.

Indexed as

ImmunoglobulinOvarian neoplasmsParaneoplastic cerebellar degenerationParaneoplastic syndromes

Identifiers

PMID33005721
PMCPMC7509787
OpenAlexW3087018842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.